Literature DB >> 25691383

Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patients.

Amma B Addai1, Jui Pandhare1, Victor Paromov1, Chinmay K Mantri1, Siddharth Pratap1, Chandravanu Dash2.   

Abstract

Epidemiologic studies suggest that cocaine abuse worsens HIV-1 disease progression. Increased viral load has been suggested to play a key role for the accelerated HIV disease among cocaine-abusing patients. The goal of this study was to investigate whether cocaine enhances proviral DNA integration as a mechanism to increase viral load. We infected CD4(+) T cells that are the primary targets of HIV-1 in vivo and treated the cells with physiologically relevant concentrations of cocaine (1 µM-100 µM). Proviral DNA integration in the host genome was measured by nested qPCR. Our results illustrated that cocaine from 1 µM through 50 µM increased HIV-1 integration in CD4(+) T cells in a dose-dependent manner. As integration can be modulated by several early postentry steps of HIV-1 infection, we examined the direct effects of cocaine on viral integration by in vitro integration assays by use of HIV-1 PICs. Our data illustrated that cocaine directly increases viral DNA integration. Furthermore, our MS analysis showed that cocaine is able to enter CD4(+) T cells and localize to the nucleus-. In summary, our data provide strong evidence that cocaine can increase HIV-1 integration in CD4(+) T cells. Therefore, we hypothesize that increased HIV-1 integration is a novel mechanism by which cocaine enhances viral load and worsens disease progression in drug-abusing HIV-1 patients. © Society for Leukocyte Biology.

Entities:  

Keywords:  Raltegravir; mass spectrometry; preintegration complex

Mesh:

Substances:

Year:  2015        PMID: 25691383      PMCID: PMC4370052          DOI: 10.1189/jlb.4A0714-356R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  71 in total

1.  Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED.

Authors:  K Blaho; B Logan; S Winbery; L Park; E Schwilke
Journal:  Am J Emerg Med       Date:  2000-09       Impact factor: 2.469

2.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Cocaine detection via rolling circle amplification of short DNA strand separated by magnetic beads.

Authors:  Cuiping Ma; Wenshuo Wang; Qing Yang; Chao Shi; Lijie Cao
Journal:  Biosens Bioelectron       Date:  2011-01-06       Impact factor: 10.618

4.  Label-free and ultrasensitive fluorescence detection of cocaine based on a strategy that utilizes DNA-templated silver nanoclusters and the nicking endonuclease-assisted signal amplification method.

Authors:  Kai Zhang; Ke Wang; Xue Zhu; Jue Zhang; Lan Xu; Biao Huang; Minhao Xie
Journal:  Chem Commun (Camb)       Date:  2014-01-07       Impact factor: 6.222

5.  Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.

Authors:  S M Evans; E J Cone; J E Henningfield
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

6.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.

Authors:  Daria J Hazuda; Steven D Young; James P Guare; Neville J Anthony; Robert P Gomez; John S Wai; Joseph P Vacca; Larry Handt; Sherri L Motzel; Hilton J Klein; Geethanjali Dornadula; Robert M Danovich; Marc V Witmer; Keith A A Wilson; Lynda Tussey; William A Schleif; Lori S Gabryelski; Lixia Jin; Michael D Miller; Danilo R Casimiro; Emilio A Emini; John W Shiver
Journal:  Science       Date:  2004-07-08       Impact factor: 47.728

Review 8.  Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

Authors:  Tangui Maurice; Rémi Martin-Fardon; Pascal Romieu; Rae R Matsumoto
Journal:  Neurosci Biobehav Rev       Date:  2002-06       Impact factor: 8.989

9.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

10.  Cocaine fatality: an unexplained blood concentration in a fatal overdose.

Authors:  F J Peretti; D S Isenschmid; B Levine; Y H Caplan; J E Smialek
Journal:  Forensic Sci Int       Date:  1990-12       Impact factor: 2.395

View more
  16 in total

1.  Blood Pressure, HIV, and Cocaine Use Among Ethnically and Racially Diverse Individuals.

Authors:  Manasi Soni; Violeta J Rodriguez; Suat Babayigit; Deborah L Jones; Mahendra Kumar
Journal:  South Med J       Date:  2018-11       Impact factor: 0.954

2.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

3.  PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.

Authors:  Muthukumar Balasubramaniam; Jing Zhou; Amma Addai; Phillip Martinez; Jui Pandhare; Christopher Aiken; Chandravanu Dash
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes.

Authors:  Muthukumar Balasubramaniam; Benem Davids; Amma B Addai; Jui Pandhare; Chandravanu Dash
Journal:  J Vis Exp       Date:  2017-02-22       Impact factor: 1.355

Review 5.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

6.  Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence.

Authors:  Olorunleke Oni; Tiffany R Glynn; Michael H Antoni; Danita Jemison; Allan Rodriguez; Mark Sharkey; Jessica Salinas; Mario Stevenson; Adam W Carrico
Journal:  Int J Behav Med       Date:  2019-10

7.  HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA.

Authors:  Nicklas Sapp; Nathaniel Burge; Khan Cox; Prem Prakash; Muthukumar Balasubramaniam; Santosh Thapa; Devin Christensen; Min Li; Jared Linderberger; Mamuka Kvaratskhelia; Jui Pandhare; Robert Craigie; Michael G Poirier; Chandravanu Dash
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

8.  Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA.

Authors:  Benem-Orom Davids; Muthukumar Balasubramaniam; Nicklas Sapp; Prem Prakash; Shalonda Ingram; Min Li; Robert Craigie; Thomas Hollis; Jui Pandhare; Chandravanu Dash
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

Review 9.  Impact of cocaine abuse on HIV pathogenesis.

Authors:  Sabyasachi Dash; Muthukumar Balasubramaniam; Fernando Villalta; Chandravanu Dash; Jui Pandhare
Journal:  Front Microbiol       Date:  2015-10-20       Impact factor: 5.640

10.  Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation.

Authors:  Chelsie Swepson; Alok Ranjan; Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  Front Microbiol       Date:  2016-06-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.